Evidence map›Paper›PMID 39025248›Full record

ArticleAmerican journal of preventive medicine2024

Pain Management Treatments and Opioid Use Disorder Risk in Medicaid Patients.

Kara E Rudolph, Nicholas T Williams, Ivan Diaz, Sarah Forrest, Katherine L Hoffman, Hillary Samples, Mark Olfson, Lisa Doan, Magdalena Cerda, Rachael K Ross

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kara E RudolphDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. Electronic address: kr2854@cumc.columbia.edu.
Nicholas T WilliamsDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Ivan DiazDivision of Biostatistics, New York University Grossman School of Medicine, New York, New York.
Sarah ForrestDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Katherine L HoffmanDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Hillary SamplesRutgers Institute for Health, Rutgers University, New Brunswick, New Jersey.
Mark OlfsonDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Lisa DoanDepartment of Anesthesiology, Perioperative Care, and Pain Medicine, New York University Grossman School of Medicine, New York, New York.
Magdalena CerdaDivision of Epidemiology, New York University Grossman School of Medicine, New York, New York.
Rachael K RossDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

Funding

Role of disability and pain in opioid overdose: mechanism and risk mitigationR01DA053243 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Kara Elizabeth Rudolph · 2022 to 2026
$3.1M
NIDA NIH HHS R01 DA053243
6 · The paper itself

Abstract

introductionPeople with chronic pain are at increased risk of opioid misuse. Less is known about the unique risk conferred by each pain management treatment, as treatments are typically implemented together, confounding their independent effects. This study estimated the extent to which pain management treatments were associated with risk of opioid use disorder (OUD) for those with chronic pain, controlling for baseline demographic and clinical confounding variables and holding other pain management treatments at their observed levels.

methodsData were analyzed in 2024 from 2 chronic pain subgroups within a cohort of non-pregnant Medicaid patients aged 35-64 years, 2016-2019, from 25 states: those with (1) chronic pain and physical disability (CPPD) (N=6,133) or (2) chronic pain without disability (CP) (N=67,438). Nine pain management treatments were considered: prescription opioid (1) dose and (2) duration; (3) number of opioid prescribers; opioid co-prescription with (4) benzo- diazepines, (5) muscle relaxants, and (6) gabapentinoids; (7) nonopioid pain prescription, (8) physical therapy, and (9) other pain treatment modality. The outcome was OUD risk.

resultsHaving opioids co-prescribed with gabapentin or benzodiazepine was statistically significantly associated with a 37-45% increased OUD risk for the CP subgroup. Opioid dose and duration also were significantly associated with increased OUD risk in this subgroup. Physical therapy was significantly associated with an 18% decreased risk of OUD in the CP subgroup.

conclusionsCoprescription of opioids with either gabapentin or benzodiazepines may substantially increase OUD risk. More positively, physical therapy may be a relatively accessible and safe pain management strategy.

Indexed as

Analgesics, OpioidChronic PainMedicaidOpioid-Related DisordersPain ManagementAdultFemaleHumansMaleMiddle AgedUnited StatesAnalgesics, Opioid

Identifiers

PMID39025248
PMCPMC11585455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.